Purepac Pharmaceutical Co.
Records under this name other than patents Purepac Pharmaceutical Co. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Purepac Pharmaceutical Co.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,214,385 | Controlled absorption diltiazem pharmaceutical formulation Formerly held Term ended Term ended Nov 23, 2019 · From the USPTO record | Term ended | Term ended Nov 23, 2019 | From the USPTO record |
| US 6,033,687 | Controlled absorption diltiazem pharmaceutical formulation Formerly held Term ended Term ended Apr 7, 2019 · From the USPTO record | Term ended | Term ended Apr 7, 2019 | From the USPTO record |
| US 7,067,151 | Controlled absorption diltiazem pharmaceutical formulation Formerly held Term ended Term ended Oct 9, 2016 · From the USPTO record | Term ended | Term ended Oct 9, 2016 | From the USPTO record |
| US 8,163,797 | Method of Treating with Stable Pravastatin Formulation Formerly held Lapsed on the fee record Ended Apr 24, 2016 · High confidence | Lapsed on the fee record | Ended Apr 24, 2016 | High confidence |
| US 6,465,012 | Pharmaceutical Tablet Formulation Containing Gabapentin with Improved Physical and Chemical Characteristics and Method of Making the Same Formerly held Lapsed on the fee record Ended Oct 15, 2010 · Low confidence | Lapsed on the fee record | Ended Oct 15, 2010 | Low confidence |
| US 6,294,198 | Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same Formerly held Lapsed on the fee record Ended Sep 25, 2009 · From the USPTO record | Lapsed on the fee record | Ended Sep 25, 2009 | From the USPTO record |
| US 5,834,024 | Controlled absorption diltiazem pharmaceutical formulation Formerly held Term ended Term ended no later than Nov 10, 2018 · Low confidence | Term ended | Term ended no later than Nov 10, 2018 | Low confidence |